RUNX1 and acute myeloid leukemia: EVI1 is overexpressed in about 10% of adult acute myeloid leukemia (AML) and acts as a marker in myeloid malignancies for an aggressive disease with poor survival [8,9,10,11,12,13,14,15,16,17].